FI3759249T3 - Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen - Google Patents
Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen Download PDFInfo
- Publication number
- FI3759249T3 FI3759249T3 FIEP19760658.5T FI19760658T FI3759249T3 FI 3759249 T3 FI3759249 T3 FI 3759249T3 FI 19760658 T FI19760658 T FI 19760658T FI 3759249 T3 FI3759249 T3 FI 3759249T3
- Authority
- FI
- Finland
- Prior art keywords
- nucleosomes
- nucleosome
- histone
- biological sample
- modification
- Prior art date
Links
- 108010047956 Nucleosomes Proteins 0.000 title claims 29
- 210000001623 nucleosome Anatomy 0.000 title claims 25
- 230000004048 modification Effects 0.000 title claims 7
- 238000012986 modification Methods 0.000 title claims 7
- 238000011002 quantification Methods 0.000 title claims 4
- 238000000034 method Methods 0.000 claims 17
- 108010033040 Histones Proteins 0.000 claims 9
- 239000012472 biological sample Substances 0.000 claims 9
- 238000001514 detection method Methods 0.000 claims 8
- 230000008836 DNA modification Effects 0.000 claims 6
- 239000004472 Lysine Substances 0.000 claims 4
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 4
- 238000003556 assay Methods 0.000 claims 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 239000003153 chemical reaction reagent Substances 0.000 claims 3
- 238000007069 methylation reaction Methods 0.000 claims 3
- 230000004481 post-translational protein modification Effects 0.000 claims 3
- OIVLITBTBDPEFK-UHFFFAOYSA-N 5,6-dihydrouracil Chemical compound O=C1CCNC(=O)N1 OIVLITBTBDPEFK-UHFFFAOYSA-N 0.000 claims 2
- RYVNIFSIEDRLSJ-UHFFFAOYSA-N 5-(hydroxymethyl)cytosine Chemical compound NC=1NC(=O)N=CC=1CO RYVNIFSIEDRLSJ-UHFFFAOYSA-N 0.000 claims 2
- 239000004475 Arginine Substances 0.000 claims 2
- 108010077544 Chromatin Proteins 0.000 claims 2
- 108090000790 Enzymes Proteins 0.000 claims 2
- 102000004190 Enzymes Human genes 0.000 claims 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 2
- 239000004473 Threonine Substances 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- 235000009697 arginine Nutrition 0.000 claims 2
- 210000003483 chromatin Anatomy 0.000 claims 2
- 239000000523 sample Substances 0.000 claims 2
- 239000000758 substrate Substances 0.000 claims 2
- KOLPWZCZXAMXKS-UHFFFAOYSA-N 3-methylcytosine Chemical compound CN1C(N)=CC=NC1=O KOLPWZCZXAMXKS-UHFFFAOYSA-N 0.000 claims 1
- BLQMCTXZEMGOJM-UHFFFAOYSA-N 5-carboxycytosine Chemical compound NC=1NC(=O)N=CC=1C(O)=O BLQMCTXZEMGOJM-UHFFFAOYSA-N 0.000 claims 1
- FHSISDGOVSHJRW-UHFFFAOYSA-N 5-formylcytosine Chemical compound NC1=NC(=O)NC=C1C=O FHSISDGOVSHJRW-UHFFFAOYSA-N 0.000 claims 1
- LRSASMSXMSNRBT-UHFFFAOYSA-N 5-methylcytosine Chemical compound CC1=CNC(=O)N=C1N LRSASMSXMSNRBT-UHFFFAOYSA-N 0.000 claims 1
- OGHAROSJZRTIOK-KQYNXXCUSA-O 7-methylguanosine Chemical compound C1=2N=C(N)NC(=O)C=2[N+](C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OGHAROSJZRTIOK-KQYNXXCUSA-O 0.000 claims 1
- 230000005730 ADP ribosylation Effects 0.000 claims 1
- 238000012815 AlphaLISA Methods 0.000 claims 1
- 238000002965 ELISA Methods 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 claims 1
- 229930010555 Inosine Natural products 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 1
- UBORTCNDUKBEOP-UHFFFAOYSA-N L-xanthosine Natural products OC1C(O)C(CO)OC1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UHFFFAOYSA-N 0.000 claims 1
- 108010059724 Micrococcal Nuclease Proteins 0.000 claims 1
- 230000006181 N-acylation Effects 0.000 claims 1
- UBORTCNDUKBEOP-HAVMAKPUSA-N Xanthosine Natural products O[C@@H]1[C@H](O)[C@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-HAVMAKPUSA-N 0.000 claims 1
- 238000006640 acetylation reaction Methods 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- 238000003016 alphascreen Methods 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000006329 citrullination Effects 0.000 claims 1
- 238000010614 crotonylation reaction Methods 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000004049 epigenetic modification Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 238000003119 immunoblot Methods 0.000 claims 1
- 229960003786 inosine Drugs 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000035772 mutation Effects 0.000 claims 1
- 231100000590 oncogenic Toxicity 0.000 claims 1
- 230000002246 oncogenic effect Effects 0.000 claims 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 claims 1
- 230000026731 phosphorylation Effects 0.000 claims 1
- 238000006366 phosphorylation reaction Methods 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000010741 sumoylation Effects 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 1
- 238000010798 ubiquitination Methods 0.000 claims 1
- UBORTCNDUKBEOP-UUOKFMHZSA-N xanthosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(NC(=O)NC2=O)=C2N=C1 UBORTCNDUKBEOP-UUOKFMHZSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6804—Nucleic acid analysis using immunogens
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/31—Endoribonucleases active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters (3.1.31)
- C12Y301/31001—Micrococcal nuclease (3.1.31.1)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material
- G01N2440/18—Post-translational modifications [PTMs] in chemical analysis of biological material citrullination
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Ecology (AREA)
- Cell Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637066P | 2018-03-01 | 2018-03-01 | |
| PCT/US2019/020283 WO2019169263A1 (en) | 2018-03-01 | 2019-03-01 | Quantification of nucleosome modifications using chemically-defined recombinant nucleosomes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| FI3759249T3 true FI3759249T3 (fi) | 2023-10-11 |
Family
ID=67805943
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP19760658.5T FI3759249T3 (fi) | 2018-03-01 | 2019-03-01 | Nukleosomimodifikaatioiden kvantitointi kemiallisesti määriteltyjä rekombinanttisia nukleosomeja käyttäen |
| FIEP23157465.8T FI4215621T3 (fi) | 2018-03-01 | 2019-03-01 | Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FIEP23157465.8T FI4215621T3 (fi) | 2018-03-01 | 2019-03-01 | Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US10787697B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3759249B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7376493B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN111918971B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019228625B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3091807A1 (cg-RX-API-DMAC7.html) |
| DK (2) | DK4215621T3 (cg-RX-API-DMAC7.html) |
| ES (2) | ES2960550T3 (cg-RX-API-DMAC7.html) |
| FI (2) | FI3759249T3 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019169263A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230003735A1 (en) * | 2019-12-02 | 2023-01-05 | Belgian Volition Srl | Use of cell free nucleosomes as biomarkers |
| US12636417B2 (en) | 2020-09-21 | 2026-05-26 | Belgian Volition Srl | Device for inline monitoring of free nucleosomes in blood |
| CN112359092B (zh) * | 2020-10-22 | 2023-09-19 | 中国农业科学院农业基因组研究所 | 一种基因组短片段文库的构建方法 |
| CA3195344A1 (en) * | 2020-11-02 | 2022-05-05 | Matthew R. MARUNDE | Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion |
| GB202108185D0 (en) * | 2021-06-08 | 2021-07-21 | Belgian Volition Sprl | Standardisation of nucleosome assays using biologically derived calibrants |
| WO2023159045A1 (en) * | 2022-02-15 | 2023-08-24 | Epicypher, Inc. | Engineered recombinant protein-binding domains as detection reagents |
| WO2024042208A1 (en) * | 2022-08-25 | 2024-02-29 | Belgian Volition Srl | Method for the detection of dementia |
| EP4602370A1 (en) * | 2022-10-12 | 2025-08-20 | Epicypher, Inc. | High efficiency antibodies for chromatin targets |
| EP4639173A1 (en) * | 2022-12-19 | 2025-10-29 | Belgian Volition SRL | Calibration |
| EP4689160A1 (en) * | 2023-04-03 | 2026-02-11 | Belgian Volition SRL | Recombinant nucleosome materials |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1008748A (en) | 1910-06-15 | 1911-11-14 | Christian Keene Snavely | Shade-roller. |
| GB0319376D0 (en) * | 2003-08-18 | 2003-09-17 | Chroma Therapeutics Ltd | Histone modification detection |
| WO2011016869A1 (en) | 2009-08-06 | 2011-02-10 | Kamran Tahamtanzadeh | Methods and compositions for drug discovery |
| EP2621942A4 (en) * | 2010-09-29 | 2015-01-21 | Gen Hospital Corp | MEANS FOR PROVIDING CONTROLS AND STANDARDS FOR IMMUNE PRECIPITATION ASSAYS |
| GB201115099D0 (en) | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes |
| GB201115095D0 (en) * | 2011-09-01 | 2011-10-19 | Singapore Volition Pte Ltd | Method for detecting nucleosomes containing nucleotides |
| GB201115098D0 (en) * | 2011-09-01 | 2011-10-19 | Belgian Volition Sa | Method for detecting nucleosomes containing histone variants |
| EP2859139B1 (en) | 2012-06-06 | 2018-08-01 | The Trustees Of Princeton University | Dna barcoding of designer mononucleosome and chromatin array libraries for the profiling of chromatin readers, writers, erasers, and modulators thereof |
| US9745384B2 (en) * | 2012-12-20 | 2017-08-29 | The Brigham And Women's Hospital, Inc. | Peptides useful for modulating histone demethylase function |
| GB201303575D0 (en) * | 2013-02-28 | 2013-04-10 | Singapore Volition Pte Ltd | Method for detecting histone modifications in nucleosomes |
| GB201400522D0 (en) * | 2014-01-13 | 2014-02-26 | Proteros Biostructure Gmbh | Nucleosome substrate assays |
| EP3102721B1 (en) * | 2014-02-03 | 2020-04-15 | The University of Chicago | Compositions and methods for quantitative assesment of dna-protein complex density |
| GB201511512D0 (en) | 2015-07-01 | 2015-08-12 | Singapore Volition Pte Ltd | Use of cell-free nucleosomes as biomarkers |
| WO2017034970A1 (en) * | 2015-08-21 | 2017-03-02 | The General Hospital Corporation | Combinatorial single molecule analysis of chromatin |
| GB201518665D0 (en) * | 2015-10-21 | 2015-12-02 | Singapore Volition Pte Ltd | Method for enrichment of cell free nucleosomes |
| EP3371601A1 (en) | 2015-11-05 | 2018-09-12 | Epizyme Inc | Flow cytometry for monitoring histone h3 methylation status |
-
2019
- 2019-03-01 CN CN201980016349.5A patent/CN111918971B/zh active Active
- 2019-03-01 EP EP19760658.5A patent/EP3759249B1/en active Active
- 2019-03-01 FI FIEP19760658.5T patent/FI3759249T3/fi active
- 2019-03-01 CA CA3091807A patent/CA3091807A1/en active Pending
- 2019-03-01 DK DK23157465.8T patent/DK4215621T3/da active
- 2019-03-01 JP JP2020545489A patent/JP7376493B2/ja active Active
- 2019-03-01 ES ES19760658T patent/ES2960550T3/es active Active
- 2019-03-01 WO PCT/US2019/020283 patent/WO2019169263A1/en not_active Ceased
- 2019-03-01 ES ES23157465T patent/ES3036655T3/es active Active
- 2019-03-01 DK DK19760658.5T patent/DK3759249T3/da active
- 2019-03-01 AU AU2019228625A patent/AU2019228625B2/en active Active
- 2019-03-01 EP EP23157465.8A patent/EP4215621B1/en active Active
- 2019-03-01 FI FIEP23157465.8T patent/FI4215621T3/fi active
- 2019-11-08 US US16/678,686 patent/US10787697B2/en active Active
-
2020
- 2020-07-24 US US16/938,256 patent/US12104199B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US10787697B2 (en) | 2020-09-29 |
| DK4215621T3 (da) | 2025-08-04 |
| JP2021515888A (ja) | 2021-06-24 |
| CN111918971A (zh) | 2020-11-10 |
| EP4215621A1 (en) | 2023-07-26 |
| CA3091807A1 (en) | 2019-09-06 |
| EP3759249B1 (en) | 2023-08-30 |
| ES3036655T3 (en) | 2025-09-23 |
| CN111918971B (zh) | 2024-09-03 |
| EP4215621B1 (en) | 2025-05-28 |
| US20200071745A1 (en) | 2020-03-05 |
| ES2960550T3 (es) | 2024-03-05 |
| AU2019228625A1 (en) | 2020-09-03 |
| US20210010058A1 (en) | 2021-01-14 |
| FI4215621T3 (fi) | 2025-07-28 |
| EP3759249A1 (en) | 2021-01-06 |
| US12104199B2 (en) | 2024-10-01 |
| DK3759249T3 (da) | 2023-10-30 |
| JP7376493B2 (ja) | 2023-11-08 |
| WO2019169263A1 (en) | 2019-09-06 |
| AU2019228625B2 (en) | 2024-11-07 |
| EP3759249A4 (en) | 2021-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Blue et al. | Transcriptome-wide identification of RNA-binding protein binding sites using seCLIP-seq | |
| FI4215621T3 (fi) | Nukleosomimodifikaatioiden kvantifiointi kemiallisesti määriteltyjä rekombinanttinukleosomeja käyttämällä | |
| Edfors et al. | Gene‐specific correlation of RNA and protein levels in human cells and tissues | |
| Xie et al. | The intriguing landscape of single‐cell protein analysis | |
| Budayeva et al. | A mass spectrometry view of stable and transient protein interactions | |
| CN107002289B (zh) | 用于定量评价dna-蛋白质复合物密度的组合物和方法 | |
| JP6687618B2 (ja) | 組換えタンパク質調製物中の残留宿主細胞タンパク質の検出 | |
| US20210095348A1 (en) | Methods and systems to perform genetically variant protein analysis, and related marker genetic protein variations and databases | |
| Ayoglu et al. | Systematic antibody and antigen-based proteomic profiling with microarrays | |
| Bomans et al. | Identification and monitoring of host cell proteins by mass spectrometry combined with high performance immunochemistry testing | |
| Yazaki et al. | HaloTag-based conjugation of proteins to barcoding-oligonucleotides | |
| Hung et al. | Microfluidic platforms for discovery and detection of molecular biomarkers | |
| WO2022094449A1 (en) | Improved assays to quantify chromatin targets using antibody-targeted enzyme digestion | |
| EP3465205A1 (en) | Antibody validation using ip-mass spectrometry | |
| WO2015122835A1 (en) | Method for protein analysis | |
| US20180172683A1 (en) | Methods for analyzing the interaction between a target protein and a ligand | |
| CN106233144A (zh) | 使用热移位测定用于鉴定指示药物应答减少的生物标记物的方法 | |
| Spisak et al. | Biomedical applications of protein microarrays | |
| Aziz et al. | Autoantibody-based diagnostic biomarkers: Technological approaches to discovery and validation | |
| EP4669770A1 (en) | SEQUENCE PROCESSES FOR POLYPEPTIDES AND ASSOCIATED COMPONENTS | |
| Treitz et al. | Combination of a SAW-biosensor with MALDI mass spectrometric analysis | |
| US20150148243A1 (en) | Method for reversible fixation or selective lysis of cell using photocleavable polymer | |
| WO2017059239A1 (en) | Methods for processing biopolymeric arrays | |
| CN102713624B (zh) | 抗Ku86自身抗体的免疫测定方法、其中使用的试剂盒、及使用其的原发性肝细胞癌的判断方法 | |
| CN107219369B (zh) | 避免信号干扰的肌原纤维蛋白丝氨酸磷酸化水平的测定方法 |